| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ceacc0d4ea78a0c031481ea91ead628 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-2102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-886 |
| filingDate |
2011-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d2b2a7f760406d8cf82cc89bd12e5c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4eac794382633689f0bb1dda84821c15 |
| publicationDate |
2011-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20110124743-A |
| titleOfInvention |
Inflammatory Bowel Disease Improver Composition |
| abstract |
The present invention discloses an inflammatory bowel disease improver composition using aloe, aloesin or aloe gel. Aloe, aloesin or aloe gel have the effect of preventing the deletion of colonic mucosal tissue in experimental animals induced by inflammatory bowel disease with DSS, and the activity of myeloperoxidase, which is used as an indicator of the degree of inflammation in intestinal injury animal models. In addition to lowering the plasma concentrations of leukotriene B4, TNF-α and PGE 2 as inflammatory mediators, they also have the activity of inhibiting the expression of TNF-α and IL-β at the gene level. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113577054-A |
| priorityDate |
2011-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |